Rapid Benzodiazepine Detoxification Using Flumazenil - 1

Yale University logo

Yale University

Status and phase

Completed
Phase 2

Conditions

Substance-Related Disorders

Treatments

Drug: Flumazenil

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000246
R01-08265-1
R01DA008265 (U.S. NIH Grant/Contract)
NIDA-08265-1

Details and patient eligibility

About

The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.

Enrollment

10 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems